Skip to main content

US ClosedU.S. Closed

DNA: Ginkgo Bioworks Holdings, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Ginkgo Bioworks Holdings, Inc. , together with its subsidiaries, develops a platform for cell engineering in the United States.

52W Range

13thpctl

Volume

1.05×avg

Market Cap

454.66MUSD

P/E Ratio

-1.4TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Ginkgo Bioworks Holdings, Inc.

DNANew York Stock Exchange·USD·Closed

Ginkgo Bioworks Holdings, Inc.

DNANew York Stock Exchange·USD·Closed

$6.96

−4.13%

$6.96

−$0.30 (4.13%)

52W Range

13thpctl

Volume

1.05×avg

Mkt Cap

454.66MUSD

P/E

-1.4TTM

Div Yield

–ann